- Home
- CLGN vs PRTG Comparison
CLGN vs PRTG Comparison
Compare CLGN & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- PRTG
- Stock Information
- Founded
- CLGN 2004
- PRTG 1973
- Country
- CLGN Israel
- PRTG British Virgin Islands
- Employees
- CLGN N/A
- PRTG N/A
- Industry
- CLGN Industrial Specialties
- PRTG Oil & Gas Production
- Sector
- CLGN Health Care
- PRTG Energy
- Exchange
- CLGN Nasdaq
- PRTG Nasdaq
- Market Cap
- CLGN 20.4M
- PRTG 17.7M
- IPO Year
- CLGN N/A
- PRTG N/A
- Fundamental
- Price
- CLGN $1.48
- PRTG $5.56
- Analyst Decision
- CLGN Strong Buy
- PRTG
- Analyst Count
- CLGN 2
- PRTG 0
- Target Price
- CLGN $11.50
- PRTG N/A
- AVG Volume (30 Days)
- CLGN 272.0K
- PRTG 24.0K
- Earning Date
- CLGN 08-19-2025
- PRTG 08-14-2025
- Dividend Yield
- CLGN N/A
- PRTG N/A
- EPS Growth
- CLGN N/A
- PRTG N/A
- EPS
- CLGN N/A
- PRTG N/A
- Revenue
- CLGN $2,472,000.00
- PRTG N/A
- Revenue This Year
- CLGN $2,177.67
- PRTG N/A
- Revenue Next Year
- CLGN $56.52
- PRTG N/A
- P/E Ratio
- CLGN N/A
- PRTG N/A
- Revenue Growth
- CLGN N/A
- PRTG N/A
- 52 Week Low
- CLGN $1.40
- PRTG $2.10
- 52 Week High
- CLGN $5.48
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- CLGN 41.46
- PRTG 31.60
- Support Level
- CLGN $1.40
- PRTG $7.51
- Resistance Level
- CLGN $1.83
- PRTG $8.17
- Average True Range (ATR)
- CLGN 0.26
- PRTG 0.71
- MACD
- CLGN -0.08
- PRTG -0.26
- Stochastic Oscillator
- CLGN 4.11
- PRTG 1.60
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.